Status:
UNKNOWN
Deep Neuromuscular Relaxation Optimizing Low-Pressure Bariatric Surgery
Lead Sponsor:
McMaster University
Conditions:
Bariatric Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to evaluate the use of deep neuromuscular blockade and low-pressure pneumoperitoneum in bariatric surgery. The investigators propose to conduct a double-blind randomized controlled tri...
Detailed Description
This will be a double-blind randomized controlled trial comparing patients undergoing a deep neuromuscular blockade with a paralytic reversal agent versus patients undergoing standard anesthetic proto...
Eligibility Criteria
Inclusion
- The patient meets NIH criteria for bariatric surgery and has not received a previous bariatric surgical procedure
- The patient is aged 18-65 years and has completed the screening and preparation process prescribed by the Ontario Bariatric Network
Exclusion
- Inability to give informed consent
- ASA \> 4
- Planned procedure other than RYGB or contraindications to RYGB
- BMI \> 55 kg/m2
- Revisional procedure
- Allergies or suspected allergies to anesthetic medications (rocuronium or sugammadex)
- Renal insufficiency (GFR \< 30ml/min)
- Family or personal history of malignant hyperthermia or personal history of neuromuscular disease
- History of chronic pain needing daily medications for the last \>3 months
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03803982
Start Date
January 1 2019
End Date
December 1 2020
Last Update
January 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.